2008
DOI: 10.1093/bioinformatics/btn354
|View full text |Cite
|
Sign up to set email alerts
|

The wisdom of the commons: ensemble tree classifiers for prostate cancer prognosis

Abstract: Using time to progression following prostatectomy as the relevant clinical endpoint, we found that ensemble tree classifiers robustly and reproducibly identified three subgroups of patients in the two clinical datasets: non-progressors, early progressors and late progressors. Moreover, the consensus classifications were independent predictors of time to progression compared to known clinical prognostic factors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2009
2009
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 30 publications
(18 citation statements)
references
References 25 publications
1
17
0
Order By: Relevance
“…A number of analysis tools have been developed to measure differences in local phylogenies, including but not limited to Phylo-HMM [10], SiPhy [11], and Coal-HMM [4,12]. While these methods detect changes in phylogenetic tree size and branch lengths, or match local regions with a set of phylogenetic hypotheses, they lack a component to learn hypotheses directly from the data and without supervision.…”
Section: Introductionmentioning
confidence: 99%
“…A number of analysis tools have been developed to measure differences in local phylogenies, including but not limited to Phylo-HMM [10], SiPhy [11], and Coal-HMM [4,12]. While these methods detect changes in phylogenetic tree size and branch lengths, or match local regions with a set of phylogenetic hypotheses, they lack a component to learn hypotheses directly from the data and without supervision.…”
Section: Introductionmentioning
confidence: 99%
“…First, the normal and disease states can be distinguished by differential expression of the identified marker genes [24]. Second, a common discriminative gene group can be mined from multiple datasets [25], or multiple classifiers can be integrated from sets of marker genes [26,27]. These approaches enhance the robustness or consensus of sets of expression-dependent marker genes in heterogeneous disease cohorts.…”
Section: Node Biomarkers For Classification and Prediction Without Nementioning
confidence: 99%
“…We have also applied a panel of advanced computational strategies, including our feature-selection algorithm, to prostate cancer datasets for the purposes of identifying cell-type signatures [45], time-to-progression predictors [46] and accurate prognostic signatures [38,47]. Prostate cancer is the most common male cancer by incidence and as with breast cancer, it is the ability to predict the metastatic behavior of a patient's cancer that is of utmost importance in prostate oncology.…”
Section: Prostate Cancer Prognostic Signaturesmentioning
confidence: 99%